Dynamic-susceptibility-contrast perfusion-weighted-imaging (DSC-PWI) in brain tumors: a brief up-to-date overview for clinical neuroradiologists.
Pons-Escoda A, Smits M.
Eur Radiol. 2023 Nov;33(11):8026-8030. doi: 10.1007/s00330-023-09729-3. Epub 2023 May 13.
PMID:37178200
Perfusion-weighted imaging with dynamic contrast enhancement (PWI/DCE) morphologic, qualitative, semiquantitative, and radiomics features predicting undifferentiated pleomorphic sarcoma (UPS) treatment response.
Valenzuela RF, Duran-Sierra E, Canjirathinkal M, Amini B, Torres KE, Benjamin RS, Ma J, Wang WL, Hwang KP, Stafford RJ, Wu C, Zarzour AM, Bishop AJ, Lo S, Madewell JE, Kumar R, Murphy WA Jr, Costelloe CM.
Neuroimaging Clin N Am. 2005 Aug;15(3):623-37, xi. doi: 10.1016/j.nic.2005.08.009.
PMID:16360593
Perfusion-Weighted Imaging: The Use of a Novel Perfusion Scoring Criteria to Improve the Assessment of Brain Tumor Recurrence versus Treatment Effects.
Mannam SS, Nwagwu CD, Sumner C, Weinberg BD, Hoang KB.
Tomography. 2023 May 23;9(3):1062-1070. doi: 10.3390/tomography9030087.
PMID:37368539
Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trial.
Xiong Y, Campbell BCV, Fisher M, Schwamm LH, Parsons M, Li H, Pan Y, Meng X, Zhao X, Wang Y.
Stroke Vasc Neurol. 2024 Feb 27;9(1):82-89. doi: 10.1136/svn-2023-002310.
PMID:37247876
Diffusion-Weighted Imaging Combined with Perfusion-Weighted Imaging under Segmentation Algorithm in the Diagnosis of Melanoma.
Shi C, Ge P, Zhao Y, Huang G.
Contrast Media Mol Imaging. 2022 Jun 27;2022:1968189. doi: 10.1155/2022/1968189. eCollection 2022.